Search Results

, monitoring, and management for patients and survivors. 17 The use of PROs in everyday clinical practice can promote better communication and shared decision-making by patients and providers, and help distinguish physical, emotional, and social issues that

cancer information and screening programs. 20 Although the benefit of prostate cancer screening is still under debate, 21 , 22 the American Cancer Society and the American Urological Association recommend shared decision-making between patients and

intermediate-risk prostate cancer to better inform shared decision-making between patients and healthcare providers. Improved patient selection and surveillance protocols may be needed to reduce the risks of AS for men with favorable intermediate-risk prostate

-reduction interventions, and the age of the women at intervention. 61 Survival estimates generated from this model can facilitate shared decision-making regarding choice of a risk reduction approach (see Table 1, available online, in these guidelines, at www

perioperative period, 35 , 36 the role of health literacy in complex surgical oncology has not previously been delineated. Because surgery for cancer is especially complex in terms of shared decision-making, perioperative instructions, and the postoperative

providers are adequately trained on anticoagulant options to provide informed recommendations when engaging in shared decision-making. Warfarin adherence can be assessed through INR monitoring. There have been concerns about adherence with LMWH given that

critical in guiding decisions regarding care, monitoring strategies, aggressiveness of therapy, and patient counseling to enable shared decision-making. 10 Yet, although overall survival, recurrence-free survival, and associated prognostic factors have

MM , Faghri A , Jacobs EA , Communication and shared decision making in the breast cancer treatment consultation: a comparative analysis of English- and Spanish-speaking patients . MDM Policy Pract 2019 ; 4 : 2381468319881651 . 31696154

and family/caregivers, whereas another panel member raised the possibility of reframing this information in an algorithm on shared decision-making. It was suggested that the current content provided important guidance on appropriate triggers for

the highest risk of VTE. We are hopeful that this clinical tool will aid informed shared decision-making between providers and patients with MM regarding VTE risk before IMiD initiation. Future prospective studies are needed to define the best VTE